TomTom unveils three new fitness trackers: $129 Touch which can analyze body composition, $249 Spark 3 with GPS tracking, and $349 Adventurer with barometer
Sean O'Kane / The Verge :
Context & Ripple Effects
TomTom's three-tier lineup slots into a wearables race where sensor depth is the differentiator: Garmin had already moved into body measurement with its smart scale and Vivosmart HR a year earlier, and the Touch's body-composition analysis answers that directly while the Spark 3 and Adventurer climb the price ladder on GPS and a barometer.
The oddity is strategic positioning: TomTom's corporate arc runs through map licensing — the Huawei deal, the expanded Microsoft partnership, the Overture Maps Foundation, and the €910M sale of its Telematics unit to Bridgestone — so these trackers are a consumer-hardware side bet competing against dedicated fitness players.
First-order effects
- Buyers now face a clean $129/$249/$349 ladder from TomTom, with each tier buying exactly one new sensor — composition analysis, GPS, barometric altimeter — rather than a bundled upgrade.
- TomTom's bands collide directly with Garmin's and Fitbit's: Garmin's later $199 Vivosport and $299 Vivoactive 3 and Fitbit's $150 Charge 3 bracket the same mid-market price points.
Second-order effects
- As prices converge across brands, rivals are pushed to compete on clinical-grade sensors instead of step counts — the path that ends with Fitbit's $330 Sense adding ECG and stress detection four years on.
- Body-composition data gives TomTom a reason to build a companion software layer around the wrist, echoing how Garmin paired its tracker with a scale to lock users into one ecosystem.
Third-order effects
- If the pattern holds, fitness wearables stratify permanently into sensor-tiered product lines rather than single flagships, with health metrics migrating from premium add-on to table stakes — squeezing vendors whose hardware lines lack a broader platform story, which is precisely TomTom's exposure given its maps-first strategy.
The trend: Fitness tracking is shifting from generic activity counts to tiered medical-grade sensing, forcing generalist hardware makers to justify their place against dedicated health platforms.